Artemisinins as a novel anti-cancer therapy: Targeting a global cancer pandemic through drug repurposing-Reference-Cited by-全球学者库

Artemisinins as a novel anti-cancer therapy: Targeting a global cancer pandemic through drug repurposing

Published:2020-12 Issue: Volume:216 Page:107706
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Augustin Yolanda,Staines Henry M.,Krishna Sanjeev

Funder

Wellcome Trust Institutional Strategic Support Fund

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference90 articles.

1. Microenvironment and tumor cells: two targets for new molecular therapies of hepatocellular carcinoma;Amicone;Transl Gastroenterol Hepatol,2018

2. The wisdom of crowds and the repurposing of artesunate as an anticancer drug;Augustin;Ecancermedicalscience,2015

3. Artesunate induces ROS- and p38 MAPK-mediated apoptosis and counteracts tumor growth in vivo in embryonal rhabdomyosarcoma cells;Beccafico;Carcinogenesis,2015

4. Artesunate induces oxidative DNA damage, sustained DNA double-strand breaks, and the ATM/ATR damage response in cancer cells;Berdelle;Molecular cancer therapeutics,2011

5. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA: a Cancer Journal for Clinicians,2018

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potentiating sorafenib efficacy against hepatocellular carcinoma via a carrier-free nanomedicine of artesunate prodrug;Smart Materials in Medicine;2024-03

2. Anticancer Drug Discovery Based on Natural Products: From Computational Approaches to Clinical Studies;Biomedicines;2024-01-16

3. Design, Synthesis, and Anti-Hepatocellular Carcinoma Evaluation of Sesquiterpene Lactone Epimers Trilobolide-6-O-isobutyrate Analogs;Molecules;2024-01-12

4. Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance;Genes & Diseases;2024-01

5. En Route to Targeted Ribosome Editing to Replenish Skin Anchor Protein LAMB3 in Junctional Epidermolysis Bullosa;JID Innovations;2024-01